Ravesanker Ezhilarasan Selected Research

Ravesanker Ezhilarasan Research Topics

16	Neoplasms (Cancer) 01/2023 - 02/2007
11	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 02/2007
8	Glioma (Gliomas) 01/2020 - 07/2013
3	Brain Neoplasms (Brain Tumor) 01/2018 - 02/2007
1	Melanoma (Melanoma, Malignant) 10/2022
1	Hypoxia (Hypoxemia) 03/2007
1	Neuroblastoma 03/2007
1	Carcinoma (Carcinomatosis) 01/2003

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2003
2	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 10/2017
2	Conditioned Culture MediaIBA 01/2018 - 03/2007
2	isothiocyanic acidIBA 03/2007 - 02/2007
2	iberin (IMSP)IBA 03/2007 - 02/2007
2	CaspasesIBA 03/2007 - 02/2007
2	Caspase 9IBA 03/2007 - 02/2007
1	Lysine (L-Lysine)FDA Link 01/2023
1	VemurafenibIBA 10/2022
1	Immune Checkpoint ProteinsIBA 10/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	talazoparibIBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	Fibrinogen (Factor I)FDA Link 01/2019
1	Polo-Like Kinase 1IBA 02/2018
1	BI 6727IBA 02/2018
1	Protein Kinase InhibitorsIBA 02/2018
1	MethyltransferasesIBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	veliparibIBA 01/2018
1	Thrombospondin 1IBA 08/2017
1	Metalloproteases (Metalloproteinases)IBA 08/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2016
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 07/2013
1	HemopexinIBA 01/2009
1	Complementary DNA (cDNA)IBA 01/2009
1	MMP-9-hemopexinIBA 01/2009
1	Bisbenzimidazole (Hoechst 33258)IBA 03/2007
1	matrigelIBA 03/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2007
1	Oxygen (Dioxygen)IBA 03/2007
1	Caspase 3 (Caspase-3)IBA 02/2007
1	MicronutrientsIBA 02/2007
1	CytokinesIBA 01/2003